Taking The Genome Further In Healthcare
Brendan FreyCrunch Network Contributor Brendan Frey is the CEO and president of Deep Genomics. How to join the networkCollecting genome data is reliable, fast and cheap. Yet, interpreting that data is unreliable, slow, and expensive — when it’s even possible. Today, genome interpretation is a burgeoning science, but it’s not yet a technology. A stricken patient has their genes sequenced and their mutations identified. But then, it can take a highly trained, and highly paid, expert many hours to make a judgment call on a single unfamiliar mutation. All too often, the result is no diagnosis, no therapy and gut wrenching uncertainty. The problem is made worse because there are not enough knowledgeable experts to handle the rising tide of genome data, and there never will be — exponential growth…
Link to Full Article: Taking The Genome Further In Healthcare
Sharing
